Raymond James Financial’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.78M Buy
338,530
+4,088
+1% +$60.2K ﹤0.01% 2623
2025
Q4
$4.74M Sell
334,442
-133,005
-28% -$1.92M ﹤0.01% 2559
2025
Q3
$6.91M Buy
467,447
+93,659
+25% +$1.4M ﹤0.01% 2214
2025
Q2
$5.66M Buy
373,788
+91,285
+32% +$1.33M ﹤0.01% 2288
2025
Q1
$4.07M Buy
282,503
+73,872
+35% +$1.13M ﹤0.01% 2466
2024
Q4
$3.16M Buy
+208,631
New +$3.35M ﹤0.01% 2631

Other funds holding BCAT

Raymond James Financial's BCAT Position: Q1 2026 in Review

Raymond James Financial increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 1.2% in Q1 2026, buying an estimated $60.2K and bringing the position to 338,530 shares worth $4.78M. The position accounts for ﹤0.01% of the portfolio, ranked #2623.

Raymond James Financial first reported a position in BCAT in Q4 2024 and has held it in 6 quarters since. The position peaked at $6.91M in Q3 2025. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.

  • Raymond James Financial held 338,530 shares of BlackRock Capital Allocation Term Trust worth $4.78M as of Q1 2026.
  • Raymond James Financial bought 4,088 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $60.2K.
  • BlackRock Capital Allocation Term Trust made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #2623 holding.
  • Raymond James Financial first reported a position in BlackRock Capital Allocation Term Trust in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's BlackRock Capital Allocation Term Trust position peaked at $6.91M in Q3 2025.
  • 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.